Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Taylor

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Nature Genetics|April 13, 2021
Minor intron retention drives clonal hematopoietic disorders and diverse cancer predispositionDaichi Inoue, Jacob T Polaski, Justin Taylor, et al.
Leukemia|November 6, 2022
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasmsMrinal M Patnaik, Amer M Zeidan, Eric Padron, et al.
Cancer Discovery|July 10, 2019
Altered Nuclear Export Signal Recognition as a Driver of OncogenesisJustin Taylor, Maria Sendino, Alexander N Gorelick, et al.
Haematologica|December 8, 2018
Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemiaWenbin Xiao, Aaron D Goldberg, Christopher A Famulare, et al.
The Journal of Clinical Investigation|September 8, 2020
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursorJustin Taylor, Mark Ta Donoghue, Caleb Ho, et al.
Nature|June 29, 2018
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutationsAndrew M Intlekofer, Alan H Shih, Bo Wang, et al.
Hemasphere|May 22, 2024
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)Fabio Efficace, Rena Buckstein, Gregory A Abel, et al.
Blood|January 10, 2023
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signaturesBenjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, et al.
Cancer Discovery|October 7, 2021
Sex-Biased <i>ZRSR2</i> Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and ApoptosisKatsuhiro Togami, Sun Sook Chung, Vikas Madan, et al.
Leukemia|July 25, 2018
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemiaAlexander C Leeksma, Justin Taylor, Bian Wu, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Nature Genetics|April 13, 2021
Minor intron retention drives clonal hematopoietic disorders and diverse cancer predispositionDaichi Inoue, Jacob T Polaski, Justin Taylor, et al.
Leukemia|November 6, 2022
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasmsMrinal M Patnaik, Amer M Zeidan, Eric Padron, et al.
Cancer Discovery|July 10, 2019
Altered Nuclear Export Signal Recognition as a Driver of OncogenesisJustin Taylor, Maria Sendino, Alexander N Gorelick, et al.
Haematologica|December 8, 2018
Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemiaWenbin Xiao, Aaron D Goldberg, Christopher A Famulare, et al.
The Journal of Clinical Investigation|September 8, 2020
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursorJustin Taylor, Mark Ta Donoghue, Caleb Ho, et al.
Nature|June 29, 2018
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutationsAndrew M Intlekofer, Alan H Shih, Bo Wang, et al.
Hemasphere|May 22, 2024
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)Fabio Efficace, Rena Buckstein, Gregory A Abel, et al.
Blood|January 10, 2023
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signaturesBenjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, et al.
Cancer Discovery|October 7, 2021
Sex-Biased <i>ZRSR2</i> Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and ApoptosisKatsuhiro Togami, Sun Sook Chung, Vikas Madan, et al.
Leukemia|July 25, 2018
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemiaAlexander C Leeksma, Justin Taylor, Bian Wu, et al.
Pageof 14